Investigation reveals cancer drugs failing quality tests worldwide, including cisplatin, oxaliplatin, cyclophosphamide, doxorubicin, methotrexate, and leucovorin.

Bad cancer drugs: the full list All the medicines that were found to be substandard by our major new investigation ...

Therefore, careful and thorough shared decision making in the context of a preoperative multidisciplinary discussion is advised when considering the administration of PBI following omission of SLNB, ...